Position in ATAI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$783,659
New position
Shares Held
148,702
first reported quarter
Ownership
0.040%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#66
of 237 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Diametric Capital, LP holds $91,993,189 across 32 Biotechnology names. ATAI ranks #11 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PGEN |
Precigen, Inc.
|
9,269,926 | $52,838,578 | |
| 2 | QURE |
uniQure N.V.
|
197,242 | $9,084,966 | |
| 3 | ABVX |
Abivax S.A.
|
51,903 | $6,916,593 | |
| 4 | ABEO |
Abeona Therapeutics Inc.
|
755,021 | $4,666,029 | |
| 5 | ZVRA |
Zevra Therapeutics, Inc.
|
231,465 | $3,319,208 | |
| 6 | UNCY |
Unicycive Therapeutics, Inc.
|
374,132 | $1,754,679 | |
| 7 | ANAB |
Anaptysbio, Inc
|
16,868 | $1,138,590 | |
| 8 | NKTR |
Nektar Therapeutics
|
15,967 | $1,114,656 |
All Filings in ATAI
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $783,659 | 148,702 | Shares | Defined | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||